You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

presenilin I (PS1) mutation

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Type II Diabetes Trial (PS1, Placebo)

Not yet recruiting
  • Type II Diabetes
  • (no location specified)
Mar 23, 2022

Alzheimer's Disease Trial in Colombia (Crenezumab, Placebo)

Active, not recruiting
  • Alzheimer's Disease
  • Armenia, Colombia
  • +3 more
Nov 21, 2022

Familial Alzheimer (FAD), PSEN1 Mutation Trial in Japan (Bromocriptine, Placebos)

Completed
  • Familial Alzheimer Disease (FAD)
  • PSEN1 Mutation
  • Nagoya, Aichi, Japan
  • +7 more
Mar 29, 2022

HIV-1-infection Trial in Saint Louis (Biktarvy Tab)

Terminated
  • HIV-1-infection
  • Biktarvy Tab
  • Saint Louis, Missouri
    Southampton Healthcare, Inc.
Jan 3, 2023

Advanced Malignant Solid Tumor, EGFR Gene Amplification, EGFR Gene Mutation Trial in Houston (Everolimus, Neratinib,

Recruiting
  • Advanced Malignant Solid Neoplasm
  • +9 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 25, 2022

Breast Cancer, Ovarian Cancer, Breast Tumors Trial in Dnipro, Kyiv (Axitinib)

Enrolling by invitation
  • Breast Cancer
  • +7 more
  • Dnipro, Ukraine
  • +1 more
Jun 17, 2023

BRCA1 Gene Mutation, BRCA2 Gene Mutation, Ovarian Serous Adenocarcinoma Trial in Buffalo, New York (biological, other, drug)

Active, not recruiting
Has Results
  • BRCA1 Gene Mutation
  • +5 more
  • Durvalumab
  • +3 more
  • Buffalo, New York
  • +1 more
Jan 20, 2023

Cholangiocarcinoma With IDH1 Mutation, Solid Tumors With IDH1 Mutation Trial in Beijing (AB-218 capsule)

Not yet recruiting
  • Cholangiocarcinoma With IDH1 Mutation
  • Solid Tumors With IDH1 Mutation
  • AB-218 capsule
  • Beijing, Beijing, China
    Peking Union Medical College Hospital, Chinese Academy of Medica
Apr 2, 2023

Quality of Life Post Salpingo-oophorectomy in BRCA1/2 & PALB2

Recruiting
  • Hereditary Breast and Ovarian Cancer
    • Barcelona, Spain
      Hospital de la Santa Creu i Sant Pau
    Jun 3, 2022

    Advanced Solid Tumor, RAS Mutation, RAF Mutation Trial in Houston, Irving (ABM-168)

    Recruiting
    • Advanced Solid Tumor
    • +3 more
    • Houston, Texas
    • +1 more
    Apr 14, 2023

    Leptomeningeal Metastasis, NSCLC Stage IV, Melanoma Stage IV Trial in Geneva, St Gallen, Zurich (intrathecal nivolumab and

    Recruiting
    • Leptomeningeal Metastasis
    • +2 more
    • intrathecal nivolumab and intrathecal ipilimumab
    • Geneva, Switzerland
    • +2 more
    Dec 18, 2022

    Lynch Syndrome, Lynch Syndrome I, Lynch Syndrome II Trial in Milan (Video capsule endoscopy)

    Recruiting
    • Lynch Syndrome
    • +7 more
    • Video capsule endoscopy
    • Milan, Lombardia, Italy
      San Raffaele Scientific Institute, Gastroenterology and Gastroin
    Jan 27, 2023

    Dominantly Inherited Alzheimer Network (DIAN)

    Recruiting
    • Alzheimer's Disease
      • Jacksonville, Florida
      • +22 more
      Feb 9, 2022

      Alzheimers Disease, Dementia, Alzheimers Disease, Familial Trial in Worldwide (Gantenerumab, Matching Placebo (Gantenerumab))

      Suspended
      • Alzheimers Disease
      • +2 more
      • Birmingham, Alabama
      • +34 more
      Jan 10, 2023

      Solid Tumors, KRAS Mutation; SOS1 Trial in Germany, Netherlands, United States (BI 1701963, Trametinib)

      Active, not recruiting
      • Solid Tumors, KRAS Mutation; SOS1
      • Boston, Massachusetts
      • +7 more
      Aug 22, 2022

      Disease Recurrence After Curative Surgery for Stage I Colon

      Recruiting
      • Colon Cancer Stage I
      • Colon Cancer
      • Colonic resection
      • Paris, France
      • +23 more
      Feb 16, 2023

      BRCA1 Gene Mutation, BRCA2 Gene Mutation, Folate Receptor Alpha Positive Trial in Columbus (other, biological, drug)

      Active, not recruiting
      • BRCA1 Gene Mutation
      • +9 more
      • Laboratory Biomarker Analysis
      • +3 more
      • Columbus, Ohio
        Ohio State University Comprehensive Cancer Center
      Sep 16, 2022

      Stage I Breast Cancer, Stage II Breast Cancer, Stage III Breast Cancer Trial in United States (Niraparib, Dostarlimab)

      Recruiting
      • Stage I Breast Cancer
      • +7 more
      • Baltimore, Maryland
      • +6 more
      Nov 11, 2022

      Solid Tumors, Adult, PIK3CA Mutation-Related Tumors, PIK3CA Mutation Trial in San Francisco (Alpelisib, Carboplatin,

      Not yet recruiting
      • Solid Tumors, Adult
      • +7 more
      • San Francisco, California
        University of California, San Francisco
      Jul 21, 2022

      Relapsed or Refractory Acute Myeloid Leukemia (AML), Untreated AML, Other IDH1-mutated Positive Hematologic Malignancies Trial

      Recruiting
      • Relapsed or Refractory Acute Myeloid Leukemia (AML)
      • +3 more
      • Birmingham, Alabama
      • +26 more
      Sep 12, 2022

      HIV-1-infection Trial in Worldwide (Dolutegravir & Rilpivirine 2 drug fixed dose combined therapy)

      Active, not recruiting
      • HIV-1-infection
      • Dolutegravir & Rilpivirine 2 drug fixed dose combined therapy
      • Antwerp, Belgium
      • +28 more
      May 23, 2022

      Limb Girdle Muscular Dystrophy, Limb-Girdle Muscular Dystrophy Type 2, LGMD2I Trial (LION-101 dose level 1, LION-101 dose level

      Not yet recruiting
      • Limb Girdle Muscular Dystrophy
      • +8 more
      • LION-101 dose level 1
      • +2 more
      • (no location specified)
      Feb 17, 2022

      Metastatic Colorectal Adenocarcinoma, Metastatic Lung Non-Small Cell Carcinoma, Metastatic Pancreatic Adenocarcinoma Trial in

      Not yet recruiting
      • Metastatic Colorectal Adenocarcinoma
      • +5 more
      • Seattle, Washington
        Fred Hutch/University of Washington Cancer Consortium
      Sep 12, 2023

      Refractory Cancer, CNS Tumors, CNS Tumor, Adult Trial in Atlanta, New York (Avutometinib)

      Recruiting
      • Refractory Cancer
      • +14 more
      • Atlanta, Georgia
      • +1 more
      Oct 23, 2023

      Metastatic Breast Cancer, Locally Advanced Breast Cancer, Advanced Breast Cancer Trial in Philadelphia (Palbociclib, Olaparib,

      Recruiting
      • Metastatic Breast Cancer
      • +4 more
      • Philadelphia, Pennsylvania
        Abramson Cancer Center of the University of Pennsylvania
      Jul 20, 2021